cerca CERCA
Domenica 25 Luglio 2021
Aggiornato: 22:55
Temi caldi

follow up

alternate text

Emofilia: Coluccia, "Emartri non sempre evidenti, medico sia presente con follow up"

 “Il medico non deve essere solo colui che prescrive ma deve monitorare lo stato articolare con il follow-up: È un modo per ritagliare in modo “sartoriale” la terapia sul paziente, anche grazie all’adozione dell’ecografia muscolo scheletrica come ausilio diagnostico”.  Così Antonella Coluccia, ematologa al Centro di emofilia e coagulopatie rare all’ospedale di Scorrano (LE), ha argomentato l’importanza del follow up nella profilassi dell’emofilia durante la settima tappa di ‘Articoliamo’, campa...

SINOMED® Completes One-Year Follow-Up of the PIONEER-III European, US and Japanese Trial of the BuMA Supreme® Coronary Drug-Eluting Stent

TIANJIN, China, July 13, 2020 /PRNewswire/ -- SINOMED, a developer of innovative neuro- and cardiovascular technologies, announced the completion of the 1-year follow-up in the PIONEER-III, randomized global trial evaluating the BuMA Supreme Drug-Eluting Coronary Stent (DES). Once completed, the company plans to submit the data to the U.S. Food and Drug Administration and Japanese Pharmaceuticals and Medical Devices Agency for the device approval. 

SINOMED® Completes Last Patient Follow-Up of the PIONEER-III Pivotal US and Japanese Trial of the BuMA Supreme® Coronary Drug-Eluting Stent

TIANJIN, China, July 6, 2020 /PRNewswire/ -- SINOMED, a developer of innovative neuro- and cardiovascular technologies, announced the completion of the 1-year follow-up in the PIONEER-III, randomized global trial evaluating the BuMA Supreme Drug-Eluting Coronary Stent (DES). Once completed, the company plans to submit the data to the U.S. Food and Drug Administration and Japanese Pharmaceuticals and Medical Devices Agency for the device approval. 

ora in
Prima pagina
articoli
in Evidenza